JAK inhibitor ‘boosts beard regrowth’
The drug can alleviate the distress of alopecia areata, say Australian dermatologists
Men who lose their beard because of alopecia areata may benefit from oral tofacitinib, Australian dermatologists report.
In what may be the first study of its kind, researchers from Sinclair Dermatology in Melbourne reviewed the records of adult male patients with scalp alopecia areata treated at their practice with the Janus kinase (JAK) inhibitor for at least three months between 2016 and 2019.
